EA201700347A2 - MEANS FOR EFFECTIVE MORATING ACUTE AND / OR CHRONIC PAIN SYNDROME AND METHOD OF ITS APPLICATION - Google Patents

MEANS FOR EFFECTIVE MORATING ACUTE AND / OR CHRONIC PAIN SYNDROME AND METHOD OF ITS APPLICATION

Info

Publication number
EA201700347A2
EA201700347A2 EA201700347A EA201700347A EA201700347A2 EA 201700347 A2 EA201700347 A2 EA 201700347A2 EA 201700347 A EA201700347 A EA 201700347A EA 201700347 A EA201700347 A EA 201700347A EA 201700347 A2 EA201700347 A2 EA 201700347A2
Authority
EA
Eurasian Patent Office
Prior art keywords
acute
chronic pain
tyr
phe
arg
Prior art date
Application number
EA201700347A
Other languages
Russian (ru)
Other versions
EA201700347A3 (en
Inventor
Вячеслав Станиславович Косоруков
Евгений Станиславович Ржанинов
Николай Васильевич Коробов
Original Assignee
Пивипи Лабс Пте. Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2016133329A external-priority patent/RU2622980C3/en
Application filed by Пивипи Лабс Пте. Лтд. filed Critical Пивипи Лабс Пте. Лтд.
Publication of EA201700347A2 publication Critical patent/EA201700347A2/en
Publication of EA201700347A3 publication Critical patent/EA201700347A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к медицине и ветеринарии, в частности к средствам для эффективного купирования острого и хронического болевого синдрома, и может быть использовано в экстремальной медицине и терапии острого и хронического болевого синдрома, в том числе и на поздних стадиях онкологических заболеваний. Заявлено средство для инъекционного и/или назального введения на основе тетрапептида последовательности H-Tyr-D-Arg-Phe-Gly-NHили H-Tyr-D-Arg-Phe-Sar-OH, для предупреждения и/или лечения острого или хронического болевого синдрома, которое, содержит в качестве действующего вещества терапевтически эффективное количество тетрапептида последовательности H-Tyr-D-Arg-Phe-Gly-NHили H-Tyr-D-Arg-Phe-Sar-OH и по меньшей мере одно вспомогательное вещество при следующем соотношение компонентов, мас.%: тетрапептид последовательности H-Tyr-D-Arg-Phe-Gly-NHили H-Tyr-D-Arg-Phe-Sar-OH - 0,01-0,5, вспомогательное вещество до 100. Также заявлен способ применения этого средства для предупреждения и/или лечения острого или хронического болевого синдрома.The invention relates to medicine and veterinary medicine, in particular to means for effective relief of acute and chronic pain syndrome, and can be used in extreme medicine and the treatment of acute and chronic pain syndrome, including in the late stages of cancer. The claimed agent for injection and / or nasal administration based on the tetrapeptide is the sequence H-Tyr-D-Arg-Phe-Gly-NH or H-Tyr-D-Arg-Phe-Sar-OH, for the prevention and / or treatment of acute or chronic pain syndrome which, as an active ingredient, contains a therapeutically effective amount of a tetrapeptide sequence H-Tyr-D-Arg-Phe-Gly-NH or H-Tyr-D-Arg-Phe-Sar-OH and at least one excipient with the following ratio components, wt.%: tetrapeptide sequence H-Tyr-D-Arg-Phe-Gly-NH or H-Tyr-D-Arg-Phe-Sar-OH - 0.01-0.5, auxiliary substance to 100. Also claimed is a method of using this agent for the prevention and / or treatment of acute or chronic pain syndrome.

EA201700347A 2016-08-12 2017-08-01 MEANS FOR EFFECTIVE MORATING ACUTE AND / OR CHRONIC PAIN SYNDROME AND METHOD OF ITS APPLICATION EA201700347A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2016133329A RU2622980C3 (en) 2016-08-12 AGENCY FOR EFFECTIVE RELIEF OF ACUTE AND/OR CHRONIC PAIN SYNDROME AND METHOD OF ITS APPLICATION

Publications (2)

Publication Number Publication Date
EA201700347A2 true EA201700347A2 (en) 2018-03-30
EA201700347A3 EA201700347A3 (en) 2018-09-28

Family

ID=59241389

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201700347A EA201700347A3 (en) 2016-08-12 2017-08-01 MEANS FOR EFFECTIVE MORATING ACUTE AND / OR CHRONIC PAIN SYNDROME AND METHOD OF ITS APPLICATION

Country Status (1)

Country Link
EA (1) EA201700347A3 (en)

Also Published As

Publication number Publication date
EA201700347A3 (en) 2018-09-28
RU2622980C1 (en) 2017-06-21

Similar Documents

Publication Publication Date Title
EA202090955A1 (en) METHODS OF USING EHMT2 INHIBITORS IN TREATMENT OR PREVENTION OF BLOOD DISORDERS
PH12017502092A1 (en) Topical pharmaceutical compositions
PH12019501414A1 (en) Amino acid compositions and methods for the treatment of liver diseases
BR112015022197A8 (en) use of a compound for the manufacture of a medicament or pharmaceutical composition for treating cataplexy
BR112017003546A2 (en) heterocyclic amides as rip1 kinase inhibitors as drugs
MX2020008258A (en) Pediatric niraparib formulations and pediatric treatment methods.
MX2019012884A (en) Combination therapy.
HRP20200009T1 (en) Angiotensin ii in combination for the treatment of hypotension
EA201791333A1 (en) GLUCAGON DERIVATIVES WITH IMPROVED STABILITY
BR112015026247A2 (en) methods for cancer treatment using tor kinase inhibitor combination therapy
BR112018015367A2 (en) nanofiber oromucosal carriers for therapeutic treatment
SG11201908234WA (en) Pharmaceutical composition comprising compound capable of penetrating blood-brain barrier as effective ingredient for preventing or treating brain cancer
PH12020500096A1 (en) Therapeutic combination of a third generation egfr tyrosine kinase inhibitor and a raf inhibitor
MX2020013692A (en) Pyrazole and imidazole compounds for inhibition of il-17 and rorgamma.
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
MX2020007222A (en) Minocycline for treating inflammatory skin conditions.
EA201700347A2 (en) MEANS FOR EFFECTIVE MORATING ACUTE AND / OR CHRONIC PAIN SYNDROME AND METHOD OF ITS APPLICATION
MX2018007377A (en) Hyaluronic acid composition for penile injections.
AR103636A1 (en) METHODS OF TREATMENT OF POSTERPEPTIC NEURALGY WITH A TOPICAL FORMULATION OF AN ESPIRO-OXINDOL COMPOUND
EA201890789A1 (en) CONTAINING ZINEOL COMPOSITION FOR THE TREATMENT OF NOSE DISEASES
EA202000298A1 (en) ANTICORONAVIRUS AGENT FOR COMBINATION THERAPY OF COVID-19 (SARS-CoV-2) AND METHOD OF TREATMENT
AR101227A1 (en) COMBINATIONS OF A N-TIAZOLIL-4-PHENOXIBENCENOSULFONAMIDE DERIVATIVE AND A PHARMACEUTICALLY ACTIVE AGENT SELECTED FROM GABAPENTINE AND PREGABALINE TO TREAT PAIN
EA202091446A1 (en) METHODS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES
MX2021001502A (en) Treatment of warts.